Daiwa Securities Group
RCKT icon

Daiwa Securities Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Daiwa Securities Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-304
Closed -$1K – 1387
2025
Q4 		$1K Hold
304
– – ﹤0.01% 1353
2025
Q3 		$1K Hold
304
– – ﹤0.01% 1317
2025
Q2 		$1K Hold
304
– – ﹤0.01% 1279
2025
Q1 		$2K Hold
304
– – ﹤0.01% 1193
2024
Q4 		$4K Hold
304
– – ﹤0.01% 1177
2024
Q3 		$6K Hold
304
– – ﹤0.01% 1161
2024
Q2 		$7K Hold
304
– – ﹤0.01% 1180
2024
Q1 		$8K Hold
304
– – ﹤0.01% 1181
2023
Q4 		$9K Hold
304
– – ﹤0.01% 1175
2023
Q3 		$6K Hold
304
– – ﹤0.01% 1145
2023
Q2 		$6K Hold
304
– – ﹤0.01% 1170
2023
Q1 		$5K Hold
304
– – ﹤0.01% 1157
2022
Q4 		$6K Buy
304
+86
+39% +$1.58K ﹤0.01% 1145
2022
Q3 		$3K Hold
218
– – ﹤0.01% 1203
2022
Q2 		$3K Hold
218
– – ﹤0.01% 1208
2022
Q1 		$3K Hold
218
– – ﹤0.01% 1225
2021
Q4 		$5K Hold
218
– – ﹤0.01% 1201
2021
Q3 		$7K Buy
218
+98
+82% +$3.57K ﹤0.01% 1159
2021
Q2 		$5K Hold
120
– – ﹤0.01% 1077
2021
Q1 		$5K Buy
120
+16
+15% +$879 ﹤0.01% 1078
2020
Q4 		$6K Sell
104
-210
-67% -$7.66K ﹤0.01% 1050
2020
Q3 		$7K Buy
314
+30
+11% +$739 ﹤0.01% 1069
2020
Q2 		$4K Hold
284
– – ﹤0.01% 1125
2020
Q1 		$4K Hold
284
– – ﹤0.01% 1121
2019
Q4 		$6K Sell
284
-37
-12% -$618 ﹤0.01% 1096
2019
Q3 		$4K Buy
321
+45
+16% +$558 ﹤0.01% 1093
2019
Q2 		$4K Hold
276
– – ﹤0.01% 1118
2019
Q1 		$5K Sell
276
-124
-31% -$1.96K ﹤0.01% 1082
2018
Q4 		$6K Buy
+400
New +$6.64K ﹤0.01% 1043

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Daiwa Securities Group's RCKT Position: Q1 2026 in Review

Daiwa Securities Group sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 304 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in RCKT in Q4 2018 and held it in 29 quarters. The position peaked at $9K in Q4 2023. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Daiwa Securities Group reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 304 Rocket Pharmaceuticals shares in Q1 2026, an estimated $1K.
  • Daiwa Securities Group first reported a position in Rocket Pharmaceuticals in Q4 2018 and held it in 29 quarters.
  • Daiwa Securities Group's Rocket Pharmaceuticals position peaked at $9K in Q4 2023.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.